| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10016040 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012545 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10011001 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10012546 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10007207 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10026202 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10034297 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020768 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10020855 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
| TVIS10047896 | HBV | ENSG00000165995.24 | protein_coding | CACNB2 | No | No | 783 | Q08289 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNB2 |
|---|---|
| DrugBank ID | DB01115 |
| Drug Name | Nifedipine |
| Target ID | BE0002354 |
| UniProt ID | Q08289 |
| Regulation Type | inhibitor |
| PubMed IDs | 11752352; 25966690 |
| Citations | Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Striessnig J, Ortner NJ, Pinggera A: Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Curr Mol Pharmacol. 2015;8(2):110-22. |
| Groups | Approved |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC |
| Pathways | Nifedipine Action Pathway |
| PharmGKB | PA450631 |
| ChEMBL | CHEMBL193 |
